TGFB1 and breast carcinoma: This combined analysis revealed a highly significant three-fold increased risk of fibrosis following radiotherapy if a breast cancer patient carries at least one variant TGFβ1 (−509T) allele (P=0.00006) and this applies to over 50% of breast cancer patients.